معرفی
Conan G. Kinsey, MD, PhD, is an Assistant Professor in the Department of Internal Medicine and an Adjunct Assistant Professor in Oncological Sciences at the University of Utah School of Medicine. As a board-certified medical oncologist and principal investigator of the Kinsey Laboratory at Huntsman Cancer Institute, his work focuses on combining targeted therapies with autophagy inhibition for pancreatic and gastrointestinal cancers, aiming for rapid clinical translation.
- Education: MD and PhD in Genetics and Medicine from University of Rochester School of Medicine and Dentistry, residency at University of Utah School of Medicine, postdoctoral training at Huntsman Cancer Institute
His research explores how protective mechanisms like autophagy enable resistance to targeted therapies in RAS/RAF-mutated cancers. The Kinsey Lab employs cancer-derived cell lines, patient-derived organoids, and xenograft models to evaluate novel therapeutic combinations.
The 12 most recent publications highlight roles in MEK1/2 and KRAS(G12C) inhibition, autophagy's role in pancreatic cancer, and strategies for overcoming resistance in NTRK1-driven cancers and melanoma. Articles span molecular oncology, pharmacology, and translational research.
Kinsey's clinical expertise includes pancreatic cancer, gastrointestinal cancers, and medical oncology at the Huntsman Cancer Institute. The lab collaborates with researchers such as Martin McMahon, Bryan Welm, and Eric Snyder.
